I have a friend kaylee right now dying from lung cancer...she was a 2 pk
or more a day smoker for most of her life. she is a young 68 years old
with no future. Yes no NO TOBACCO!
Nancy Berry
- Original Message
From: kaylee [EMAIL PROTECTED]
To: MTWT [EMAIL PROTECTED]
Sent: Wednesday, March 21, 2007 11:31:58 PM
Subject: [cia-drugs] DON'T USE TOBACCO? Neither Do I
I am aware that this has little to do
with the drug war (except another possible prohibited substance), the prison
situation, free speech (well, maybe free speech), world peace or constitutional
law, but considering that lung cancer could easily affect you or someone you
love, perhaps you can graciously overlook the fact that I'm off topic again and
do something simple but wise for our future health.
Kay
Lee
Petition for the Lung Cancer Aliance
http://www.lungcanc eralliance. org/involved/ sign_the_ petition. php
LUNG CANCER IS THE #1 CAUSE OF CANCER DEATH ANNUALLY AND HAS THE
LEAST FUNDING Perhaps it's because, as part of the tobacco demonization
effort, we have come to believe that people who use
tobacco deserve cancer? Please show some compassion and common
sense...not all people who die from lung cancer ever used tobacco...
Just as not all people who use tobacco ever get lung cancer. This killer
disease
requires more funding, more research, and more effective treatments.
Lung cancer continues to be the single biggest cancer killer. In
2006, an estimated 162,460 will die of lung cancer; more people than breast,
prostate, colon, liver, melanoma, and kidney cancers combined. Few people are
even aware that lung cancer kills three times as many men as prostate cancer,
and nearly twice as many women as breast cancer. Prostate cancer has a 99
percent 5-year survival rate and breast cancer has an 88 percent 5-year
survival
rate.
Over 50 percent of new lung cancer cases will be diagnosed
at a very late stage—Stage IIIb or IV. Lung cancer has a 5-year survival rate
of
only 15 percent. That means that 85 percent of people who get lung cancer die
within five years.
THIS MUST BE CHANGED.
Join the 14757 people who have already signed or downloaded the petition to
make lung cancer a national public health priority.
I join with the Lung Cancer Alliance to call on the President of the
United States and members of Congress to increase funding to at least an
additional 250 million dollars per year, for: medical research for early
detection and curative treatment for lung cancer, and education and support for
people diagnosed with lung cancer.
We, the undersigned, call on the President of the United
States and the Congress to make early detection, treatment, and chemoprevention
of lung cancer a national public health priority.
We also call for adequate new funding to increase the
overall 5-year survival rate to at least 50 percent by 2015.
SIGN THE PETITION and Please pass this on.
http://www.lungcanc eralliance. org/involved/ sign_the_ petition. php
!--
#ygrp-mlmsg {font-size:13px;font-family:arial, helvetica, clean, sans-serif;}
#ygrp-mlmsg table {font-size:inherit;font:100%;}
#ygrp-mlmsg select, input, textarea {font:99% arial, helvetica, clean,
sans-serif;}
#ygrp-mlmsg pre, code {font:115% monospace;}
#ygrp-mlmsg * {line-height:1.22em;}
#ygrp-text{
font-family:Georgia;
}
#ygrp-text p{
margin:0 0 1em 0;}
#ygrp-tpmsgs{
font-family:Arial;
clear:both;}
#ygrp-vitnav{
padding-top:10px;font-family:Verdana;font-size:77%;margin:0;}
#ygrp-vitnav a{
padding:0 1px;}
#ygrp-actbar{
clear:both;margin:25px 0;white-space:nowrap;color:#666;text-align:right;}
#ygrp-actbar .left{
float:left;white-space:nowrap;}
.bld{font-weight:bold;}
#ygrp-grft{
font-family:Verdana;font-size:77%;padding:15px 0;}
#ygrp-ft{
font-family:verdana;font-size:77%;border-top:1px solid #666;
padding:5px 0;
}
#ygrp-mlmsg #logo{
padding-bottom:10px;}
#ygrp-vital{
background-color:#e0ecee;margin-bottom:20px;padding:2px 0 8px 8px;}
#ygrp-vital #vithd{
font-size:77%;font-family:Verdana;font-weight:bold;color:#333;text-transform:uppercase;}
#ygrp-vital ul{
padding:0;margin:2px 0;}
#ygrp-vital ul li{
list-style-type:none;clear:both;border:1px solid #e0ecee;
}
#ygrp-vital ul li .ct{
font-weight:bold;color:#ff7900;float:right;width:2em;text-align:right;padding-right:.5em;}
#ygrp-vital ul li .cat{
font-weight:bold;}
#ygrp-vital a {
text-decoration:none;}
#ygrp-vital a:hover{
text-decoration:underline;}
#ygrp-sponsor #hd{
color:#999;font-size:77%;}
#ygrp-sponsor #ov{
padding:6px 13px;background-color:#e0ecee;margin-bottom:20px;}
#ygrp-sponsor #ov ul{
padding:0 0 0 8px;margin:0;}
#ygrp-sponsor #ov li{
list-style-type:square;padding:6px 0;font-size:77%;}
#ygrp-sponsor #ov li a{
text-decoration:none;font-size:130%;}
#ygrp-sponsor #nc {
background-color:#eee;margin-bottom:20px;padding:0 8px;}
#ygrp-sponsor .ad{
padding:8px 0;}
#ygrp-sponsor .ad #hd1{
font-family:Arial
